Eduardo Bossone1, Francesco Ferrara, Ekkehard Grünig. 1. aDepartment of Cardiology and Cardiac Surgery, University Hospital 'Scuola Medica Salernitana', Salerno, Italy bCenter of Pulmonary Hypertension, Thoraxclinig at University Hospital Heidelberg, Heidelberg, Germany.
Abstract
PURPOSE OF REVIEW: Pulmonary hypertension is a progressive disease of the pulmonary vasculature characterized by increased vascular resistance and pressure overload of the right ventricle. This review aims to describe the diagnostic and prognostic role of echocardiography in pulmonary hypertension with particular consideration of relative strengths, weaknesses and new advances. RECENT FINDINGS: Although right heart catheterization (RHC) remains the gold standard, echocardiography represents an accessible and feasible real-world tool for screening, differential diagnostic, follow-up assessments and risk stratification in pulmonary hypertension. In the context of clinical scenario and multimaging approach, echocardiography provides accurate measurements of pulmonary haemodynamics, either at rest and/or during exercise, and is particularly useful in ruling out secondary causes of pulmonary hypertension and/or detecting preclinical stages. The use of advanced noninvasive imaging techniques may provide additional information in assessing right heart structure and function. SUMMARY: Advances in echocardiography and the multimodality imaging approach continue to provide new understandings and opportunities for the study of the right heart-pulmonary circulation unit in pulmonary hypertension.
PURPOSE OF REVIEW: Pulmonary hypertension is a progressive disease of the pulmonary vasculature characterized by increased vascular resistance and pressure overload of the right ventricle. This review aims to describe the diagnostic and prognostic role of echocardiography in pulmonary hypertension with particular consideration of relative strengths, weaknesses and new advances. RECENT FINDINGS: Although right heart catheterization (RHC) remains the gold standard, echocardiography represents an accessible and feasible real-world tool for screening, differential diagnostic, follow-up assessments and risk stratification in pulmonary hypertension. In the context of clinical scenario and multimaging approach, echocardiography provides accurate measurements of pulmonary haemodynamics, either at rest and/or during exercise, and is particularly useful in ruling out secondary causes of pulmonary hypertension and/or detecting preclinical stages. The use of advanced noninvasive imaging techniques may provide additional information in assessing right heart structure and function. SUMMARY: Advances in echocardiography and the multimodality imaging approach continue to provide new understandings and opportunities for the study of the right heart-pulmonary circulation unit in pulmonary hypertension.
Authors: Eugenio Picano; Quirino Ciampi; Rodolfo Citro; Antonello D'Andrea; Maria Chiara Scali; Lauro Cortigiani; Iacopo Olivotto; Fabio Mori; Maurizio Galderisi; Marco Fabio Costantino; Lorenza Pratali; Giovanni Di Salvo; Eduardo Bossone; Francesco Ferrara; Luna Gargani; Fausto Rigo; Nicola Gaibazzi; Giuseppe Limongelli; Giuseppe Pacileo; Maria Grazia Andreassi; Bruno Pinamonti; Laura Massa; Marco A R Torres; Marcelo H Miglioranza; Clarissa Borguezan Daros; José Luis de Castro E Silva Pretto; Branko Beleslin; Ana Djordjevic-Dikic; Albert Varga; Attila Palinkas; Gergely Agoston; Dario Gregori; Paolo Trambaiolo; Sergio Severino; Ayana Arystan; Marco Paterni; Clara Carpeggiani; Paolo Colonna Journal: Cardiovasc Ultrasound Date: 2017-01-18 Impact factor: 2.062
Authors: David G Kiely; David Levin; Paul Hassoun; David D Ivy; Pei-Ni Jone; Jumaa Bwika; Steven M Kawut; Jim Lordan; Angela Lungu; Jeremy Mazurek; Shahin Moledina; Horst Olschewski; Andrew Peacock; Goverdhan Dutt Puri; Farbod Rahaghi; Michal Schafer; Mark Schiebler; Nicholas Screaton; Merryn Tawhai; Edwin Jr Van Beek; Anton Vonk-Noordegraaf; Rebecca R Vanderpool; John Wort; Lan Zhao; Jim Wild; Jens Vogel-Claussen; Andrew J Swift Journal: Pulm Circ Date: 2019-03-18 Impact factor: 3.017